Since the early 1970s, Fenbendazole, an anthelmintic medicine, has been employed to cure parasitic worm infections in dogs. However, a number of scientific publications examined by peers and published in scholarly journals indicate that this medication may also be able to effectively treat a range of dangerous tumors in humans.
Research states that fenbendazole stands out from all other cancer treatments due to the following essential components:
Previous research has verified that fenbendazole is effective in treating different types of cancer. It has been utilized to remedy large B-cell lymphoma with metastases, metastatic malignancies, bladder cancer, and renal cell carcinoma. Fenbendazole is an economical medication, and can be obtained without prescription in many nations.
It has been reported that the same cancer-fighting ability of a chemotherapy treatment involving plant alkaloids, such as Taxol, can be found in this substance. Its toxicity is much less than traditional chemotherapies due to its specifically designed mode of operation and its proven safety. Studies and evidence demonstrate that some forms of cancer are provoked by certain parasites, microbes, and viruses.
In actuality, it could be that this is occurring in a much wider range of cases than what has been documented, particularly in cases where the immune system is not as strong and a genetic deficiency is present. Consequently, it may be sensible to have anti-worm, anti-parasitic, anti-lactic acid and other medicinal methods as part of primary cancer therapies, together with the customary cancer treatments.
Fenbendazole is not regularly employed to treat humans as often as mebendazole. It is usually employed for animals affected by parasites such as hookworms, whipworms, roundworms and certain tapeworms. Initially seen in studies a few years ago for the purpose of controlling cancer, under the name Safe-Guard or Panacur, it recently returned to the spotlight due to a tale of one man curing his own small cell lung cancer using this substance.
A website and a Facebook page have been created to showcase this particular man’s story and the experiences of other patients who have obtained successful treatment through the use of benzimidazole family of chemicals. The individuals, who had an assortment of cancers, including melanoma, non-small cell lung cancer, prostate cancer, colorectal cancer, and stage 4 pancreatic cancer, benefited considerably. The newly published research has further developed to support current and growing scientific evidence pertaining to the potential of numerous drugs within the benzimidazole family as cancer treatments. Therefore, with the same effectiveness as mebendazole, people may consider purchasing fenbendazole for their cancer treatment.
Several studies have indicated that fenbendazole performs better than mebendazole. In one of those experiments, it was discovered to be far superior to mebendazole and other medications when dealing with a particular type of opportunistic fungus known as Cryptococcus neoformans. This fungus exists in many regions and may result in Cryptococcus meningitis in certain individuals.
Different studies have concluded that Fenbendazole can be used to treat cancer, as it has the necessary qualities. The research reveals that Fenbendazole has a mild effect on microtubules and can interact with various biological pathways to bring about cell death in cancer cells.
Evidence is mounting that Fenbendazole has the capability to interfere with microtubule functions and subsequently effect anti-tumor activities. As a result, it could be a helpful therapeutic agent against cancer, likely because it has an impact on a variety of cell pathways connected with the destruction of cancer cells.
The authors of the study determined that fenbendazole not only could interfere with the proteasomal activity and cellular microtubules of cancer cells, but it also had the capacity to prevent glucose uptake. It does this by blocking the stimulus for the transport of GLUT4 and its insulin-induced flow into the plasma membrane, hindering its absorption of glucose. Fenbendazole hampers the linear movement of GLUT4 by interfering with the microtubules, significantly curtailing the sugar absorption brought about by the insulin.
Fenbendazole has a similar mechanism to colchicine, but unlike other vinca alkaloids, it does not clash with various chemotherapies. Rather, it boosts the effectiveness of medical therapies for cancer, including surgery, radiation, berberine, and sodium dichloroacetate.
Additionally, a scholarly paper has been put out to the public showing that fenbendazole (and analogous medicines) may activate the genomic protein called p53. This particular protein is referred to as the “Guardian of the Genome” and functions as a controller of tumors; yet, its control may not be as efficient in specific kinds of cancer. In like manner, the Nature paper brought to light the amazing effectiveness of fenbendazole when linked with DCA.
Can people safely consume Fenbendazole?
A study available from the European Medicine Agency shows that, even though Fenbendazole is generally used to treat parasitic worms in animals, it appears to be safe for humans when taken in a single dose of up to 2000 milligrams, or 500 milligrams for ten consecutive days. However, thus far, the safety of long-term human exposure has not been confirmed due to the fact that these kinds of parasitic infections are usually gone in less than two weeks.
Though this is the case, many people have consumed fenbendazole on an everyday basis for various years in an effort to either avert cancer from returning or to cure it. Research has demonstrated that this treatment is innocuous with scarcely any deleterious consequences. Visit: https://www.fenbendazole.org/